Whitepaper: The impacts of Brexit on the bio/pharmaceutical industry
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
List view / Grid view
On 23 June 2016, the decision was made on the European Union referendum for the United Kingdom to withdraw from the European Union.
Systech is the global technology leader in supply chain security and product authentication. For more than 30 years, we have put technology on the line...
North America dominates the global market for pharmaceutical glass packaging, due to the region’s technical innovation and strong demand for pharmaceutical products...
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
The global pharmaceutical industry has been expanding steadily at varying rates of regional growth; the pace of growth being relatively slow in the developed, matured markets but rapid in developing nations...
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them...
A new project led by the Karolinska Institutet in Sweden aims to improve the standards of drug safety in East Africa...
A Europe-wide policy covering the generic pharmaceuticals market would significantly boost growth in the sector, reveals a new report from Frost & Sullivan...
OPTEL GROUP, a leading global provider of traceability systems for diverse industries, namely for pharmaceuticals, medical devices, healthcare, food and natural resources, announced today that it will be exhibiting an entirely serialised line at this year’s edition of Achema, from 11 - 15 June 2018, in Frankfurt, Germany, at Stand F31…
Collaboration also includes strategic investment by Aptar Pharma; will add connectivity to drug-delivery routes to improve adherence and treatment outcomes...
A new guide intended to promote a collaborative working effort between biomanufacturers and their suppliers is now available from BPOG, the BioPhorum Operations Group...
Developing serialisation programmes is a key concern for pharmaceutical companies. Much of the decision-making is being driven by fast-approaching deadlines for compliance - both in the EU and US.
In this application, a Principal Component Analysis (PCA) method was found to be successful in identifying the various stearates...
In this issue: Sample preparation - is it possible to have too much? Developing successful over-the-counter syrup packaging for the highly regulated EU market. In-line process PAT in continous wet granulation, and much more...